GLP-1 medications are a class of therapies that help regulate appetite, blood sugar, and metabolic health. This page explains how they work, who they may help, and how they are used safely in a clinical setting.
GLP-1 medications mimic a natural hormone called glucagon-like peptide-1, which plays a role in regulating appetite, blood sugar, and digestion.
These medications were originally developed to treat type 2 diabetes, but research has shown they can also support weight loss and metabolic health in certain patients.
Common examples include medications such as semaglutide and tirzepatide.
GLP-1 Receptor Agonist
Mechanism of Action
GLP-1 medications help reduce hunger signals in the brain.
Food leaves the stomach more slowly, helping patients feel fuller longer.
They support improved glucose control by influencing insulin signaling.
These medications may support broader metabolic improvements in some patients.
GLP-1 medications are powerful therapies and should be used under the supervision of a qualified clinician. A medical evaluation helps determine whether these medications are appropriate based on a patient's health history, medications, and metabolic profile. At SCULPT, treatment decisions are guided by clinical evaluation and biomarker review rather than automatic prescribing.
Before treatment
Lab and health data
Medication follow-up
Weight loss with GLP-1 medications is designed to be gradual and sustainable. While every patient responds differently, many people notice consistent progress over several months when medication is combined with supportive lifestyle changes.
Many patients begin noticing reduced hunger and improved portion control during the first several weeks of treatment. Some early weight loss may occur as the body adjusts to the medication and dietary habits begin to change.
At this stage, many patients report improved appetite regulation and more consistent weight loss. Energy levels often stabilize as the body adapts to the new metabolic signals created by treatment.
After several months of treatment, many patients begin noticing more visible changes in body composition and overall weight. Providers may review progress and adjust treatment plans if needed to support continued success.
By six months, many patients have achieved meaningful weight loss and improved metabolic health markers. Ongoing medical guidance helps support long-term maintenance and continued progress.
Individual results vary. Weight loss outcomes depend on many factors including starting weight, treatment plan, lifestyle habits, and overall health.
Understanding Your Options
(Weekly Injection)
Best for:
Patients seeking reliable, predictable results with a once-weekly schedule
(Weekly Injection)
Best for:
Patients seeking maximum weight loss and metabolic improvement
(Daily Injection)
Best for:
Patients who prefer a lower-intensity option or cannot tolerate newer medications
Most Effective
Tirzepatide
Balanced & Proven
Semaglutide
Milder Alternative
Liraglutide
Your Treatment is Personalized: Treatment selection is personalized based on your goals, medical history, and response—ensuring the right balance of effectiveness, tolerability, and long-term sustainability.
Sculpt Medicine offers clinician-guided metabolic care and education to help patients make informed decisions.
Start Your Evaluation